Board and Spokespersons
A member at the board of directors represents each partnering institution as well as the research fields of medical, bio-molecular, physiological, behavioral and psychological neuroscience, with a maximum of 10 active board members in total.
The board of directors is responsible for coordinating research plans within the CBBS and advises the spokespersons on topics of strategic development and funding decisions.
Prof. Dr. Daniela Dieterich Institute for Pharmacology and Toxicology, Otto von Guericke University (spokeswoman)
short-CV
|
Prof. Dr. Ildiko Rita Dunay Department of Inflammation and Neurodegeneration, Otto von Guericke University
short-CV
|
Prof. Dr. med. Emrah Düzel Institute of Cognitive Neurology and Dementia Research, Otto von Guericke University and Speaker of German Center for Neurodegenerative Diseases
short-CV
|
Prof. Dr. med. Hans-Jochen Heinze Medical Director of University Hospital, Otto von Guericke University, Department Behavioral Neurology, Leibniz Institute for Neurobiology Otto-von-Guericke-Universität, Magdeburg
short-CV
|
Prof. Dr. Volkmar Leßmann Institute for Physiology, Otto von Guericke University
short-CV
|
Prof. Dr. Tömme Noesselt Institute for Psychology, der Otto von Guericke University (spokesman)
short-CV
|
Prof. Dr. Frank Ohl Department of Systems Physiology of Learning, Leibniz Institute for Neurobiology Otto von Guericke University
short-CV
|
<
Prof. Dr. Stefan Pollmann Institute for Psychology Otto von Guericke University
short-CV
|
Prof. Dr. Oliver Stork Department of Genetics & Molecular Neurobiology Fakultät für Naturwissenschaften Otto von Guericke University
short-CV
|
Prof. Dr. med. Markus Ullsperger Department of Neuropsychology, Otto von Guericke University
short-CV
|
apl. Prof. Dr. Constanze Seidenbecher Scientific Administration, Leibniz Institute for Neurobiology Magdeburg
(consultative member)
|